Real-World Persistence and Effectiveness of Upadacitinib versus Other Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors in Australian Patients with Rheumatoid Arthritis.
Youssef P, Ciciriello S, Tahir T, Leadbetter J, Butcher B, Calao M, Walsh N, O'Sullivan C, Smith T, Littlejohn G.
Youssef P, et al.
Rheumatol Ther. 2025 Feb;12(1):173-202. doi: 10.1007/s40744-024-00736-4. Epub 2025 Jan 6.
Rheumatol Ther. 2025.
PMID: 39757285
Free PMC article.
INTRODUCTION: This study sought to describe treatment patterns, persistence, and effectiveness of upadacitinib (UPA) alone and compared to other Janus kinase inhibitors (JAKis) or tumor necrosis factor inhibitors (TNFis) in …
INTRODUCTION: This study sought to describe treatment patterns, persistence, and effectiveness of upadacitinib (UPA) alone and …